Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid:26686338 | ||||
pmid:26657161 | ||||
pmid:24725852 | ||||
pmid:24611780 | ||||
pmid:16504354 | ||||
pmid:16286429 | ||||
pmid:21479479 | ||||
pmid:18571185 | ||||
pmid:29168243 | ||||
pmid:29027212 | ||||
pmid: | ||||
pmid:6209078 | ||||
pmid:9278881 | ||||
Dai P et al. | Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. | 2015 | AAPS J | pmid:25762448 |
Gombotz H et al. | Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. | 2000 | Acta Anaesthesiol Scand | pmid:10903019 |
Peduto VA et al. | Stimulation of drug-metabolizing enzymes by nitrous oxide in the rat. | 1983 | Acta Anaesthesiol Scand | pmid:6141696 |
Lv YK et al. | Poly[dimethyl-ammonium [aquadi-μ(2)-oxalato-yttriate(III)] trihydrate]. | 2011 | Acta Crystallogr Sect E Struct Rep Online | pmid:21836844 |
Lv YK et al. | Poly[dimethyl-ammonium [aquadi-μ(2)-oxalato-samarate(III)] trihydrate]. | 2011 | Acta Crystallogr Sect E Struct Rep Online | pmid:21836843 |
Kim YH et al. | Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. | 2009 | Acta Haematol. | pmid:19332985 |
Nonaka D et al. | Gelatinous bone marrow transformation complicated by self-induced malnutrition. | 1998 | Acta Haematol. | pmid:9792939 |
Kawasaki H et al. | Effect of corticosteroid treatment on bilirubin metabolism in chronic aggressive hepatitis. | 1977 | Acta Hepatogastroenterol (Stuttg) | pmid:883466 |
Budillon G et al. | Urinary excretion of D-glucaric acid, total glucuronic acid and total porphyrins in porphyria cutanea tarda. | 1978 | Acta Hepatogastroenterol (Stuttg) | pmid:696201 |
Horváth T et al. | Drug metabolism in alcoholic liver disease. | 1982 | Acta Med Acad Sci Hung | pmid:7185242 |
Várkonyi A et al. | Non-specific drug-metabolizing enzyme activity in Gilbert disease. | 1984 | Acta Med Hung | pmid:6440117 |
Horváth T et al. | Disorders of biotransformation during the progression of alcoholic liver disease. | 1986 | Acta Med Hung | pmid:3601579 |
Horváth T et al. | Correlation between biochemical tests, parameters of drug elimination and hepatic enzyme induction in chronic liver diseases. | 1983 | Acta Med Hung | pmid:6674914 |
Krafft A et al. | Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia. | 2000 | Acta Obstet Gynecol Scand | pmid:10949245 |
Cassimos C et al. | Erythrocyte glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice. | 1977 | Acta Paediatr Scand | pmid:868519 |
Talafant E et al. | Serum gamma-glutamyl transpeptidase activity and urinary D-glucaric acid excretion in newborns in the first week of life. Effects of phenobarbital and nicethamide combination. | 1976 | Acta Paediatr Scand | pmid:11634 |
Anbu AT et al. | Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin. | 2005 | Acta Paediatr. | pmid:16431410 |
Marselos M | Genetic variation of drug-metabolizing enzymes in the wistar rat. | 1976 | Acta Pharmacol Toxicol (Copenh) | pmid:821309 |
Pár A et al. | Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease. | 1984 | Acta Physiol Hung | pmid:6152369 |
Horváth T et al. | Drug metabolism in drug-induced liver diseases: pathogenetic role of active metabolites. | 1989 | Acta Physiol Hung | pmid:2596319 |
Del Ninno E et al. | [The d-glucaric acid test in the evaluation of the inductive properties of phenobarbital and spironalactone]. | 1974 | Acta Vitaminol. Enzymol. | pmid:4480343 |
Bolaños L et al. | Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. | 2008 | Adv Perit Dial | pmid:18986009 |
Roots I et al. | Comparison of methods to study enzyme induction in man. | 1975 | Adv. Exp. Med. Biol. | pmid:239546 |
Calcium-D-glucarate. | 2002 | Altern Med Rev | pmid:12197785 | |
Lord RS and Bralley JA | Clinical applications of urinary organic acids. Part I: Detoxification markers. | 2008 | Altern Med Rev | pmid:18950247 |
Weiersmüller A et al. | The influence of prednisolone on hepatic function in normal subjects. Effects on galactose elimination capacity, sulfobromophthalein transport maximum and storage capacity, and D-glucaric acid output. | 1977 | Am J Dig Dis | pmid:857663 |
Carrella M et al. | An evaluation of urinary D-glucaric acid excretion during acute hepatitis in man. | 1978 | Am J Dig Dis | pmid:619622 |
Nguyen TV | Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients. | 2009 | Am J Health Syst Pharm | pmid:19498125 |
Wall GC and Pauly RA | Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. | 2008 | Am J Health Syst Pharm | pmid:18192261 |
Thomas J and Martinez A | Blood conservation in the critically ill. | 2007 | Am J Health Syst Pharm | pmid:17687066 |
Newman MA et al. | Urinary biological monitoring markers of anticancer drug exposure in oncology nurses. | 1994 | Am J Public Health | pmid:8179062 |
Buchanan N et al. | Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor. | 1979 | Am. J. Clin. Nutr. | pmid:506967 |
Kulnigg S et al. | Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. | 2009 | Am. J. Gastroenterol. | pmid:19491860 |
Gasche C et al. | Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. | 2001 | Am. J. Gastroenterol. | pmid:11513178 |
Schröder O et al. | Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. | 2005 | Am. J. Gastroenterol. | pmid:16279906 |
Derman R et al. | A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. | 2017 | Am. J. Hematol. | pmid:28052413 |
Hetzel D et al. | A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. | 2014 | Am. J. Hematol. | pmid:24639149 |